Clinical Trial of DA-5212 in Patients with Functional Dyspepsia
NCT05842408 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 384
Last updated 2024-12-13
Summary
This study is to evaluate efficacy and safety of DA-5212 in patients with functional dyspepsia
Conditions
- Functional Dyspepsia
Interventions
- DRUG
-
DA-5212
Test drug: DA-5212
- DRUG
-
DA-5212-R
Control drug: DA-5212-R
Sponsors & Collaborators
-
Dong-A ST Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-06
- Primary Completion
- 2024-09-04
- Completion
- 2024-09-04
Countries
- South Korea
Study Locations
More Related Trials
-
A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects
NCT03558425 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia
NCT00333372 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects
NCT04703374 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)
NCT03184324 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
NCT05813561 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III, Long-term, Open-label Safety Study of Z-338
NCT01973790 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia
NCT00323817 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of EsoDuo®
NCT06430047 ·Status: RECRUITING ·Phase: PHASE4
-
YM443 in Subjects With Functional Dyspepsia
NCT00102310 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial for the Evaluation of the Efficacy and Safety of EDL on Dyspepsia
NCT04482478 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease
NCT02556021 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
NCT00232024 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia
NCT00232102 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula
NCT02425423 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD)
NCT03943992 ·Status: COMPLETED ·Phase: PHASE3
-
Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain
NCT01637571 ·Status: WITHDRAWN ·Phase: PHASE4
-
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
NCT00232089 ·Status: COMPLETED ·Phase: PHASE3
-
The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis
NCT07079540 ·Status: COMPLETED ·Phase: PHASE3
-
Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
NCT02351960 ·Status: COMPLETED ·Phase: PHASE4
-
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia
NCT00232037 ·Status: COMPLETED ·Phase: PHASE3
-
An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients
NCT01370863 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132
NCT04755985 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg
NCT03928470 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers
NCT01705275 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Acotiamide on Gastric Motility and Satiation in Healthy Volunteers
NCT03402984 ·Status: COMPLETED ·Phase: NA